A patchwork effort is trying to fill CDC’s vaccine voidnews2025-09-17T22:25:11+00:00September 17th, 2025|Endpoints News|
Regeneron heads to FDA with treatment for very rare bone diseasenews2025-09-17T19:31:06+00:00September 17th, 2025|Endpoints News|
Pfizer, Novartis, BMS, Lilly and others targeted in FDA’s TV ad crackdownnews2025-09-16T19:27:05+00:00September 16th, 2025|Endpoints News|
Covid-19 vaccine makers sidelined ahead of upcoming ACIP meeting, sources saynews2025-09-15T21:22:10+00:00September 15th, 2025|Endpoints News|
RFK Jr. adds five new ACIP panelists ahead of key meetingnews2025-09-15T19:46:29+00:00September 15th, 2025|Endpoints News|
FDA calls out AstraZeneca’s flu vaccine TV ad amid regulatory blitznews2025-09-15T18:25:20+00:00September 15th, 2025|Endpoints News|
Top drug regulator pushes back on report that FDA wants to ‘abandon’ some adcommsnews2025-09-12T18:22:06+00:00September 12th, 2025|Endpoints News|
Prasad regains chief medical and scientific officer roles at FDAnews2025-09-11T17:25:23+00:00September 11th, 2025|Endpoints News|
RFK Jr.’s ‘historic changes’ to drug ads would trigger range of ripple effectsnews2025-09-11T15:41:30+00:00September 11th, 2025|Endpoints News|
Intercept pulls liver disease drug from market as FDA puts clinical trials on holdnews2025-09-11T14:48:53+00:00September 11th, 2025|Endpoints News|
